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Tuesday, March 2, 2021
During this COVID-19 pandemic and other future events, the CDM has been
and will continue to be a source of reliable information, education and models
for mitigation, preparedness, response, and recovery. We hope this
informational document has helped provide you filtered and actionable
information. As the pace of new information and changes occur, we will
evaluate the current once per week to determine if this information should be
provided on a more frequent basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics
Total Cases

Total Deaths

Total
Recovered

Total Tested

Worldwide

114,499,553

2,540,340

64,690,916

Not Available

United States

28,664,604

514,660

Not Available

351,801,124

New Jersey

792,496

23,273

Not Available

10,660,578

New York

1,650,303

47,719

Not Available

38,281,073

Connecticut

282,626

7,651

Not Available

6,403,426

Information as of 3/2/21 at 1000 EST. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates

●
●
●
●
●
●
●
●
●
●

Delivered All Hazards Disaster Response course to members of different public safety
agencies from New York and Connecticut
Presented lecture regarding disaster medicine, emergency management and COVID-19 to
graduating class of NYU Rory Meyers College of Nursing students
Coordinating and overseeing COVID-19 screenings at NYMC campus
Continue to partner with local agencies such as Westchester Department of Emergency
Services to ensure ongoing collaboration with all public safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.
Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline
responders in the hospital and in the field.
Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using firstperson experiences to highlight current trends.

To view the Center for Disaster Medicine's newest webinar, please click here - The
COVID-19 Vaccine: What to Tell Your Patients

The White House
The official website of the White House delivers bold action and immediate relief for American
families as the country grapples with converging crises. This includes actions to control the
COVID-19 pandemic, provide economic relief, tackle climate change, and advance racial equity
and civil rights, as well as immediate actions to reform our immigration system and restore
America’s standing in the world.
https://www.whitehouse.gov

Health and Human Services (HHS)
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
A research team funded by the National Institutes of Health has launched a study to assess
performance and usability of a smartphone app paired with the Quidel QuickVue At-Home
COVID-19 Test, which just received an Emergency Use Authorization (EUA) from the U.S. Food
and Drug Administration for use with a prescription. The home test was supported by NIH
through the Rapid Acceleration of Diagnostics (RADx) initiative, which has spurred the
development and commercial availability of millions of COVID-19 tests over the past year.
https://www.nih.gov/news-events/news-releases/nih-evaluate-covid-19-home-testing-system
The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the
Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19
vaccine, called Ad.26.COV2S or JNJ-78436725. The Janssen vaccine is a recombinant vector
vaccine that uses a human adenovirus to express the spike protein found on the surface of the
SARS-CoV-2 virus that causes COVID-19.
https://www.nih.gov/news-events/news-releases/statement-nih-barda-fda-emergency-useauthorization-janssen-covid-19-vaccine
People who have had evidence of a prior infection with SARS-CoV-2, the virus that causes
COVID-19, appear to be well protected against being reinfected with the virus, at least for a few
months, according to a newly published study from the National Cancer Institute (NCI). This
finding may explain why reinfection appears to be relatively rare, and it could have important
public health implications, including decisions about returning to physical workplaces, school
attendance, the prioritization of vaccine distribution, and other activities.
https://www.nih.gov/news-events/news-releases/nih-study-finds-people-sars-cov-2-antibodiesmay-have-low-risk-future-infection
View the latest COVID-19 information from NIH
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
As of February 26, 2021, 332 tests and sample collection devices are authorized by the
FDA under emergency use authorizations (EUAs). These include 248 molecular tests and
sample collection devices, 70 antibody tests, and 14 antigen tests. There are 37
molecular authorizations that can be used with home-collected samples. There is one
molecular prescription at-home test, one antigen prescription at-home test, and one overthe-counter (OTC) at-home antigen test.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-updatefebruary-26-2021
On February 27, 2021, the U.S. Food and Drug Administration issued an emergency use
authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019
(COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in
individuals 18 years of age and older. The EUA for the Janssen COVID-19 Vaccine was
issued to Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson &
Johnson.
https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-useauthorization-third-covid-19-vaccine
For the latest overall FDA information about COVID-19
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19

Centers for Disease Control and Prevention (CDC)
CDC is closely monitoring mutations in the virus genome that alter the characteristics and
cause the virus to act differently in ways that are significant to public health (e.g., causes
more severe disease, spreads more easily between humans, requires different
treatments, changes the effectiveness of current vaccines). It’s important to understand
that genetic mutations are expected, and some variants can spread and become
predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC is responding to the COVID-19 pandemic by learning more about how the disease
spreads and affects people and communities. CDC’s Morbidity and Mortality Weekly
Report publishes the results of COVID-19 outbreak investigations. CDC’s scientific journal
Emerging Infectious Diseases has published dozens of studies by researchers studying
COVID-19 since the pandemic began.
https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research.html
CDC provides update on COVID-19 cases caused by variants in the United States.

https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
For daily updates of cases in United States
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html

Center for Medicare and Medicaid Services (CMS)
In accordance with the Executive Order President Biden signed on January 21, 2021, the
Centers for Medicare & Medicaid Services (CMS), together with the Department of Labor
and the Department of the Treasury, (collectively, the Departments) issued new guidance
today removing barriers to COVID-19 diagnostic testing and vaccinations and
strengthening requirements that plans and issuers cover diagnostic testing without cost
sharing.
https://www.cms.gov/newsroom/press-releases/biden-administration-strengthensrequirements-plans-and-issuers-cover-covid-19-diagnostic-testing
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page

Vaccines

In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of March 2, 2021, the FDA has granted Emergency
Use Authorization (EUA) to Pfizer BioNTech, Moderna and Janssen/Johnson & Johnson.
Now with three vaccines with EUA, the goal is to vaccinate a larger number of persons in
the coming months throughout the United States. As additional vaccines are granted
EUA, information for those vaccines will also be included.
FDA grants Emergency Use Authorization (EUA) to Janssen COVID-19 Vaccine- On
February 27, 2021, the U.S. Food and Drug Administration issued an emergency use
authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019
(COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S. for use in
individuals 18 years of age and older.
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019covid-19/janssen-covid-19-vaccine
On December 18, 2020, the U.S. Food and Drug Administration issued an emergency use
authorization (EUA) for the second vaccine for the prevention of coronavirus disease
2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). The emergency use authorization allows the Moderna COVID-19 Vaccine to be
distributed in the U.S for use in individuals 18 years of age and older.
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019covid-19/moderna-covid-19-vaccine
On December 11, 2020, the U.S. Food and Drug Administration issued the first
emergency use authorization (EUA) for a vaccine for the prevention of coronavirus
disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2

(SARS-CoV-2) in individuals 16 years of age and older. The emergency use authorization
allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S.
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019covid-19/pfizer-biontech-covid-19-vaccine
CDC provides overall U.S. COVID-19 Vaccine, deliveries and administration, maps,
charts, and data updated daily by 8 p.m. This section represents all vaccine partners
including jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal
Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations
Media Statement from CDC Director Rochelle P. Walensky, M.D., M.P.H., on Signing the
Advisory Committee on Immunization Practices’ Recommendation to Use Janssen’s
COVID-19 Vaccine in People 18 and Older
https://www.cdc.gov/media/releases/2021/s0228-JJ-vaccine.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,
and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
New York State Governor Andrew M. Cuomo today announced that the New York State
Clinical Advisory Task Force unanimously recommended use of Janssen
Pharmaceuticals/Johnson & Johnson's COVID-19 vaccine in New York State, following
the FDA's advisory committee's recommendation for emergency use authorization. New
York expects to receive approximately 164,800 doses of the Johnson & Johnson vaccine
this week, pending final FDA authorization. The added doses will supplement New York
State's expected Week 12 supply of 422,780 first doses and 290,500 second doses from
Pfizer and Moderna, for a total of approximately 878,080 doses. This will be New York
State's highest-ever weekly vaccine allocation.
https://www.governor.ny.gov/news/governor-cuomo-announces-state-vaccine-task-forceunanimously-recommends-jj-vaccine-one-year
The COVID-19 vaccines are here. Supply from the Federal Government is extremely
limited. Additional New Yorkers will become eligible as the vaccine supply increases.
While the vaccination process is underway, every New Yorker should wear a mask, social
distance and avoid small and large gatherings. Governor Cuomo revised the eligibility list
of persons to include any New Yorker of any age with certain comorbidities and
underlying conditions effective February 15, 2021.
https://covid19vaccine.health.ny.gov/phased-distribution-vaccine#phase-1a---phase-1b

The new NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on
the distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
NYS DOH releases instructions for New York State-operated vaccination sites
https://covid19vaccine.health.ny.gov/
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/

Educational Institution Information
•

Higher Education
o A years-long push to lessen the incentive for for-profit institutions to
recruit veterans as students took a major step toward becoming law with
the House’s passage of a $1.9 trillion coronavirus relief package
Saturday morning. Included in the package, which would also send
another $40 billion in aid to the nation’s colleges and universities during
the pandemic, was a provision tightening the controversial "90-10" rule.
The for-profit industry, however, is expected to try to kill the change when
the Senate takes up the relief package this week, warning that the
change pushed by Democrats would inadvertently lead to for-profits
accepting fewer veterans and members of the military. The proposal did
survive one hurdle Monday night when the Senate's parliamentarian ruled
that it could stay in the bill, according to groups on both sides of the
debate. For-profit industry lobbyists had hoped the parliamentarian would
rule that the measure goes beyond what is allowable in the funding bill,
as she did in killing the Democratic proposal to raise the federal minimum
wage. https://www.insidehighered.com/news/2021/03/02/provision-covid19-relief-bill-would-ease-incentives-profits-target-veterans
o More than half of students worldwide, and three-quarters in the U.S., said
their mental health has suffered during the COVID-19 pandemic,
according to a new survey of nearly 17,000 undergraduate students
across 21 countries commissioned by the nonprofit arm of Chegg,
a controversial textbook rental and educational technology company.
Chegg.org commissioned the polling company Yonder to interview
16,839 undergraduates across the 21 countries last fall, with sample
sizes in the various countries ranging from 500 to about 1,000. Seventyfive percent of American students surveyed said their mental health had
suffered due to the pandemic, second only to Brazil (76 percent) and
similar to the percentage of Canadian students who said the same
(73 percent). Worldwide, across the nearly two dozen countries where
students were surveyed, 56 percent of students said their mental health

had suffered during the pandemic.
https://www.insidehighered.com/news/2021/03/01/global-student-surveyfocuses-mental-health-and-financial-and-other-pressures
•

K-12
o

o

As state leaders regroup to plan a path forward, district administrators are
"at the mercy" of their decisions, said education policy expert Cara
Jackson, an associate partner at Bellwether Education Partners. Aside
from the remote option, states can shorten assessments, offer multiple
testing windows and extend testing until fall 2021, according to the
Education Department. Many of the options, except online administration,
would bring remote students back into buildings, although the guidance
says students should not come in solely for standardized testing if health
and safety conditions do not allow for that. James Cantonwine, director of
research and assessment for Washington's Peninsula School District,
said that means jumping logistical hurdles, including scheduling and
space constraints, to allow for safe conditions. In addition, Marion said
schools may need testing, contact tracing and additional resources to
successfully carry out their efforts. https://www.k12dive.com/news/howwill-districts-prepare-for-2020-21-summative-testing/595565/
States must still do all they can to measure student learning levels so
schools can make progress in advancing educational equity, identifying
student needs and targeting resources for interventions, the department
said in a letter addressed to chief state school officers. In what it calls
“significant flexibility,” the department is encouraging states to consider
waivers that would not require that calculation of progress toward longterm goals and measurements of interim progress or indicators. A waiver
also would allow states to forgo the requirement to implement and report
results of its accountability system. States would still need to maintain all
state and local report card requirements and disaggregate data by
student groups. However, reporting related to accountability, like school
ratings, may not be required. https://www.k12dive.com/news/ed-deptstates-must-assess-students-but-with-flexibilities/595529/

Clinical Trials
To view the latest information on 4,636 clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=

American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates

New York
•

•

•

Governor Andrew M. Cuomo announced 12 community-based pop-up vaccination sites
coming online this week at community centers, public housing complexes and cultural
centers. These sites are expected to vaccinate more than 3,700 people throughout the
week, with more sites coming online every week. Since January 15, more than 100
community-based pop-up sites administered over 46,000 first doses of the COVID-19
vaccine dose. As has been the case with previous pop-up sites, these sites will be reestablished in three weeks to administer second doses. Moving forward as the federal
vaccine supply increases, New York will continue to establish these sites at all 33
NYCHA Senior Housing Developments, which house more than 7,600 seniors. Pop-up
locations will also continue to be established at other public housing complexes
statewide, as well as at more than 300 churches and cultural centers which have
volunteered to house these sites through Governor Cuomo's Vaccine Equity Task Force.
https://www.governor.ny.gov/news/governor-cuomo-announces-12-community-basedpop-vaccination-sites-coming-online-week-vaccinate
Governor Cuomo announced the State will partner with local health departments to
include vaccination sites for the 65+ population across New York State. These sites will
be in partnership with local health departments and, where needed, will provide
assistance to New Yorkers with transportation to and from the vaccination facilities and
special support for paperwork regarding their vaccination. As New York State’s vaccine
allocations increase, these 65+ facilities and appointments will be enabled from
additional supply from the federal government. Counties across New York State will be
getting an increased supply of Moderna vaccine for this purpose starting next week.
https://www.governor.ny.gov/news/governor-cuomo-announces-state-expandvaccination-network-include-sites-designed-serve-65-plus
Governor Cuomo today announced that the New York State Clinical Advisory Task
Force unanimously recommended use of Janssen Pharmaceuticals/Johnson &
Johnson's COVID-19 vaccine in New York State, following the FDA's advisory
committee's recommendation for emergency use authorization. New York expects to
receive approximately 164,800 doses of the Johnson & Johnson vaccine this week,
pending final FDA authorization. The added doses will supplement New York State's
expected Week 12 supply of 422,780 first doses and 290,500 second doses from Pfizer
and Moderna, for a total of approximately 878,080 doses. This will be New York State's
highest-ever weekly vaccine allocation. https://www.governor.ny.gov/news/governorcuomo-announces-state-vaccine-task-force-unanimously-recommends-jj-vaccine-oneyear

New York State Department of Health (DOH)
For a list of positive cases by county in New York State
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.

https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

New Jersey
•

•

Governor Phil Murphy and Secretary of Higher Education Dr. Brian Bridges announced
that $29.5 million in federal funding will be available to New Jersey’s institutions of
higher education amid the ongoing COVID-19 pandemic to support the goals of
the State Plan for Higher Education through a competitive challenge grant and address
student food insecurities across college campuses. About $28.5 million in funding from
the U.S. Department of Education through the Governor's Emergency Education Relief
(GEER II) Fund will be awarded to New Jersey’s public and public-mission private
institutions that receive state operating aid to implement vetted best practices that
increase college completion, address barriers to student success, and develop
sustainable systemic reforms. Another $1 million will be awarded to public institutions to
combat food insecurity among students.
https://nj.gov/governor/news/news/562021/approved/20210224b.shtml
On March 1, Governor Murphy announced the expansion of eligibility for more frontline
essential workers and high-risk groups in New Jersey’s COVID-19 vaccination program.
Eligible groups include educators and staff in pre-k through 12th grade
settings, childcare workers, and transportation workers, among others. For a full list of
eligible groups, please visit
https://nj.gov/governor/news/news/562021/approved/20210301a.shtml

Connecticut
•

Governor Ned Lamont announced that his administration has filed an objection to
motions under consideration at the Public Utilities Regulatory Authority (PURA) to
approve plans submitted by Eversource Energy and the United Illuminating Company to
begin allowing for the disconnection of customers for non-payment for the time since

PURA first implemented a shut-off moratorium in response to the COVID-19 pandemic.
The Lamont administration’s objections, which was made through the leadership of the
Department of Energy and Environmental Protection (DEEP), noted that resuming
disconnections at this time would have a devastating impact on many customers who
are still struggling to pay their utility bills in the midst of the ongoing COVID-19
pandemic. https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2021/022021/Governor-Lamont-Urges-Regulators-To-Reject-Plan-for-Resumption-of-ServiceDisconnections

Local Updates
New York Blood Center (NYBC)
Fox 5 Good Day New York’s recent segment highlighted the lifesaving power of convalescent
plasma donation for critical COVID-19 patients. Brian Strauss was hospitalized with coronavirus and
received lifesaving convalescent plasma. He was grateful for the opportunity to meet and thank his
plasma donors Robert McCord and Patrice Piretti, RN.
https://www.nybc.org/news/articles/good-day-ny-features-emotional-meeting-covid-convalescentplasma-recipient-his-donors/
For the latest updated NYBC information about COVID-19:

https://nybc.org/covid-19/

New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page
For the latest COVID-19 information from NYC DOHMH
https://www1.nyc.gov/site/doh/covid/covid-19-main.page

Westchester County Department of Health
For the latest breakdown of positive cases in Westchester County as of February 28, 2021
https://wcgis.maps.arcgis.com/apps/opsdashboard/index.html#/280339d96db14efd9cc304dba0f3a71
d
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams
offering earlier access to vaccines.
https://health.westchestergov.com/2019-novel-coronavirus

Putnam County Department of Health
Breakdown of positive cases by towns in Putnam County as of March 1, 2021https://www.putnamcountyny.com/breakdown-of-positive-cases-by-towns-in-putnam-county-3-12021/
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/

Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of March 1, 2021
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm

Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of March 1, 2021
https://ocnygis.maps.arcgis.com/apps/opsdashboard/index.html#/21de1fb5ce0c480f95dc0cf2b8b83b
71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information

Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
March 1, 2021

https://www.arcgis.com/apps/opsdashboard/index.html#/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/

Healthcare
GNYHA provides updated New York Stat guidance information regarding Johnson & Johnson
COVID-19 Vaccine Emergency Use Authorization
https://www.gnyha.org/news/johnson-updated-new-york-state-guidance/
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

Center for Disaster Medicine Media
New York Medical College Leadership News:
New York State's COVID Positivity Rate Drops Again With Johnson & Johnson Vaccine
Approval On Horizon
CBS New York
2/24/2021
https://newyork.cbslocal.com/video/5336421-new-york-states-covid-positivity-rate-dropsagain-with-johnson-johnson-vaccine-approval-on-horizon/

Robert Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
Could You Get the Vaccine Injected in Your Butt?
Slate
2/23/2021
https://slate.com/technology/2021/02/can-you-get-the-vaccine-in-your-butt.html
Robert Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
Can You Choose Which COVID-19 Vaccine You Get?
HuffPost
3/1/2021
https://www.huffpost.com/entry/can-you-choose-which-covidvaccine_l_6039597ec5b6d7794adeeb92
Robert Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
FDA panel endorses Johnson & Johnson's COVID-19 vaccine
Fox News
2/27/2021
https://www.foxnews.com/health/fda-panel-endorses-johnson-johnsons-covid-19-vaccine
Robert Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
Johnson & Johnson COVID-19 vaccine headed for FDA committee vote: What the
experts say
Fox News
2/27/2021
https://www.foxnews.com/health/johnson-johnson-covid-19-vaccine-fda-committee-voteexperts-weigh-in
Robert Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
Johnson & Johnson COVID-19 vaccine headed for FDA committee vote: What the
experts say
Fox News
2/27/2021
https://www.foxnews.com/health/johnson-johnson-covid-19-vaccine-fda-committee-voteexperts-weigh-in
Robert Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs

Every effort is made to provide accurate and complete information in this newsletter. However, New
York Medical College cannot guarantee that there will be no errors. NYMC makes no claims, promises or
guarantees about the accuracy, completeness, or adequacy of the contents of the newsletters or the
articles linked herein and further expressly disclaims liability for errors and omissions in the contents of
this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the
advice of your physician or other qualified health provider with any questions you may have regarding a
medical condition.

New York Medical College
Center for Disaster Medicine
7 Dana Road Suite 511
Valhalla, New York 10595
914-594-1750

https://www.nymc.edu/center-for-disaster-medicine/

